MarketInOut Stock Screener Log In | Sign Up

Charles River Laboratories International Inc

NYSE • Healthcare • Diagnostics & Research • Quote as of 10/30/2026
Charles River Laboratories International Inc stock price and volume chart

Company Profile

IndustryDiagnostics & Research
SectorHealthcare
ExchangeNYSE
Market Capitalization17,312 mln
Float47.20 mln
Earnings Date11/04/2026

Piotroski F-Score

5 / 9
Neutral

Beneish M-Score

-3.11
Reliable

1-Year Forecast

318.87
Limited downside

Relative Strength

99 / 100
Top performer

Debt / Equity

1.07
Elevated leverage

Pre-Tax Margin

-5%
Marginally loss-making

Business Description

Founded in 1947 and based in Wilmington, Massachusetts, Charles River Laboratories International helps pharmaceutical and biotechnology companies bring new medicines to market by providing research animals, laboratory testing, and drug development support services across North America, Europe, Asia, and beyond. The company breeds and supplies specially raised rodents for scientific research while also offering genetic modeling, disease screening, and animal health diagnostics to research teams worldwide. Its testing divisions evaluate the safety and effectiveness of new drugs, biologics, and other therapeutic compounds, covering everything from early discovery through preclinical trials. On the manufacturing side, Charles River provides quality control testing and contract production services to help ensure that pharmaceutical and consumer products meet regulatory standards before reaching patients.

Key Fundamentals

EPS-4.80
ROE-7.59
RPS81.86
ROIC7.93
ROA-3.18
Interest Cover5.09
EBITDA, mln220
EV / EBITDA90.99
EV / EBIT-259
Revenue, mln3,999
EV / Revenue5.02

Quote Details

Last 359.41
Change -16.69 (-4.44%)
Open 372.99
Volume 1,483,200
Turnover 533,076,896
Average Volume 1,166,350

Financial Ratios

Pre-Tax Profit Margin-5
Leverage Ratio2.65
Current Ratio1.35
Price / Book6.03
Price / Cash Flow29.93
Price / Free Cash Flow47.31
Debt / Equity1.07
Price / Sales4.39
PEG Ratio0.12

Financial Strength

Altman Z-Score3.02
Piotroski F-Score 5 / 9
Beneish M-Score-3.11
Price to Intrinsic Value2.70
1-Year Target Price318.87
Shiller PE Ratio65.48
Short Ratio2.77
Short % of Float6.86

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 4.07% 89 / 100   
1 Month 25.3% 98 / 100   
2 Months 60.24% 99 / 100   
6 Months 117% 100 / 100   
1 Year 99.51% 98 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog